N-[[2-(2-methoxyethyl)-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazin-3-yl]methyl]-6-methylpyridine-3-carboxamide
C18H22N4O3 — CID 91920410
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[2-(2-methoxyethyl)-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazin-3-yl]methyl]-6-methylpyridine-3-carboxamide
N-[[2-(2-methoxyethyl)-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazin-3-yl]methyl]-6-methylpyridine-3-carboxamide (PubChem CID 91920410) has the molecular formula C18H22N4O3 and a molecular weight of 342.40 g/mol. Its IUPAC name is N-[[2-(2-methoxyethyl)-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazin-3-yl]methyl]-6-methylpyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[[2-(2-methoxyethyl)-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazin-3-yl]methyl]-6-methylpyridine-3-carboxamide |
|---|---|
| PubChem CID | 91920410 |
| Molecular Formula | C18H22N4O3 |
| Molecular Weight | 342.40 g/mol |
| Exact Mass | 342.17 |
| IUPAC Name | N-[[2-(2-methoxyethyl)-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazin-3-yl]methyl]-6-methylpyridine-3-carboxamide |
| SMILES | COCCN1C(=O)c2cccn2CC1CNC(=O)c1ccc(C)nc1 |
| InChI | InChI=1S/C18H22N4O3/c1-13-5-6-14(10-19-13)17(23)20-11-15-12-21-7-3-4-16(21)18(24)22(15)8-9-25-2/h3-7,10,15H,8-9,11-12H2,1-2H3,(H,20,23) |
| InChIKey | FJSVSRPDOZTKSD-UHFFFAOYSA-N |
| XLogP | 1.09 |
| TPSA | 76.46 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 342.40 |
| LogP ≤ 5 | 1.09 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91920410 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.